Critical Path Institute

Sep 04, 2025

C-Path's Translational Therapeutics Accelerator Marks Record Year with Seven BRIDGe Awards Advancing Potential Therapies Across Cancer, Infectious Disease, Neurology and Immunology

Jun 16, 2025

C-Path's New Paper in Nature Reviews Drug Discovery Highlights How to Maximize the Regulatory Impact of Consortium-Based Projects

May 08, 2025

Critical Path Institute Celebrates 20 Years of Advancing Drug Development through Innovation and Collaboration

Sep 12, 2024

C-Path's Inaugural Global Impact Conference Charts the Future of Drug Development

Sep 09, 2024

FDA Issues 'Letter of Support' Encouraging Use of Synuclein-based Biomarker, aSyn-SAA, in Clinical Trials in Parkinson's and Related Diseases

Mar 28, 2024

C-Path Launches Clinical Trial Simulator for Duchenne Muscular Dystrophy Research

Jun 23, 2020

C-Path Launches CURE Drug Repurposing Collaboratory to Accelerate Identification of New Uses of Existing Drugs to Treat Infectious Diseases, Including COVID-19

Jun 22, 2020

Transplant Therapeutics Consortium Receives Acceptance of Letter-of-Intent for iBox Scoring System as a Reasonably Likely Surrogate Endpoint from the Biomarker Qualification Program

Jun 17, 2020

C-Path's Transplant Therapeutics Consortium Receives Acceptance of Letter of Intent for iBox Scoring System (Composite Biomarker Panel) as a Reasonably Likely Surrogate Endpoint

Jun 15, 2020

Koneksa Joins the Critical Path Institute ePRO Consortium